{ "items": [ "\n\n
\n \n Journal article\n \n
\n \n\n \n \n \nHaarsma J. et al, (2020), Schizophr Res
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nHaarsma J. et al, (2020), psyarxiv
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nHuys Q. et al, (2020), Neuropsychopharmacology
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nPulcu E. et al, (2020), BIOLOGICAL PSYCHIATRY, 87, S305 - S306
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nBrowning M., (2020), BIOLOGICAL PSYCHIATRY, 87, S51 - S51
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nReinecke A. et al, (2020), Behav Res Ther, 129
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nHarmer CJ. and Browning M., (2020), Biol Psychiatry, 87, 382 - 383
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nPenton-Voak IS. et al, (2020), Psychol Med, 1 - 9
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nOverman MJ. et al, (2020), Cognitive Therapy and Research
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nBROWNING M. et al, (2019), Biological Psychiatry
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nKappelmann N. et al, (2019), J Behav Ther Exp Psychiatry, 68
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nBROWNING M., (2019), Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMURPHY S. et al, (2019), Psychological Medicine
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nPULCU E. and BROWNING M., (2019), Trends in Cognitive Sciences
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nJonassen R. et al, (2019), BMC Psychiatry, 19
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nKappelmann N. et al, (2019), biorxiv
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nBukala BR. et al, (2019), J Psychopharmacol, 33, 255 - 257
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nBrowning M., (2019), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, S12 - S12
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nShkreli L. et al, (2019), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, S710 - S711
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nBrowning M. et al, (2019), Eur Neuropsychopharmacol, 29, 66 - 75
\n \n \n \n\n
\n \n \n \n